Literature DB >> 6859939

Clinical pharmacology of netilmicin in the newborn.

A M Phillips, R D Milner.   

Abstract

The plasma peak, trough, and peak-trough concentrations of netilmicin given to preterm and term infants were measured after different regimens to determine which dosage would provide satisfactory peak and trough concentrations. In infants aged less than 7 days, dosage regimens of 3.0 or 2.5 mg/kg every 12 hours gave satisfactory peak levels (range 5.2-12.0 micrograms/ml) but troughs were above the desirable maximum level of 3 micrograms/ml in more than half the preterm infants. Subsequently a dosage regimen of 3.0 mg/kg immediately followed by 2.0 mg/kg every 12 hours resulted in trough levels that exceeded 3 micrograms/ml in only 2 of 25 preterm determinations and never in term infants, yet gave satisfactory peak levels (range 4.5-7.4 micrograms/ml). In preterm infants aged 4 to 7 weeks a dosage of 3 mg/kg every 8 hours gave satisfactory peak and trough levels.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859939      PMCID: PMC1628002          DOI: 10.1136/adc.58.6.451

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Clinical pharmacology of gentamicin in the newborn infant.

Authors:  R D Milner; J Ross; D J Froud; J A Davis
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

Review 2.  Use of aminoglycosides in the neonate.

Authors:  L Riff; V Schauf
Journal:  Semin Perinatol       Date:  1982-04       Impact factor: 3.300

3.  Tolerance and efficacy of netilmicin in pediatric patients with gram-negative pneumonia.

Authors:  I Brook
Journal:  Chemotherapy       Date:  1980       Impact factor: 2.544

4.  Safety and efficacy of netilmicin in neonates with serious systemic infections.

Authors:  H Trujillo; R Manotas; J Loaiza
Journal:  J Int Med Res       Date:  1981       Impact factor: 1.671

5.  Comparison of the nephrotoxicity of netilmicin and gentamicin in rats.

Authors:  R L Bowman; F J Silverblatt; G J Kaloyanides
Journal:  Antimicrob Agents Chemother       Date:  1977-10       Impact factor: 5.191

6.  Biological activity of netilmicin, a broad-spectrum semisynthetic aminoglycoside antibiotic.

Authors:  G H Miller; G Arcieri; M J Weinstein; J A Waitz
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

7.  Pharmacokinetic properties of netilmicin in newborn infants.

Authors:  J D Siegel; G H McCracken; M L Thomas; N Threlkeld
Journal:  Antimicrob Agents Chemother       Date:  1979-02       Impact factor: 5.191

8.  Netilmicin use in pediatric patients.

Authors:  V Chindasilpa; V Schauf; L R Hamilton; L J Riff
Journal:  Dev Pharmacol Ther       Date:  1980

9.  Netilmicin: efficacy and tolerance in the treatment of systemic infections in neonates.

Authors:  B Peitersen; H Hørlyk; M Nielsen; J Prag; B Korner; A M Heilesen; A Friis-Møller
Journal:  Scand J Infect Dis Suppl       Date:  1980

10.  Netilmicin and gentamicin: comparative pharmacology in humans.

Authors:  L J Riff; G Moreschi
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

  10 in total
  2 in total

1.  Pharmacokinetics of netilmicin in premature infants.

Authors:  R J Kuhn; M C Nahata; D A Powell; R G Bickers
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 2.  Netilmicin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; S Chaplin; R H Sayce; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.